307 related articles for article (PubMed ID: 2543942)
21. Expression of ras and myc oncogenes in human hepatocellular carcinoma and non-neoplastic liver tissues.
Tiniakos D; Spandidos DA; Kakkanas A; Pintzas A; Pollice L; Tiniakos G
Anticancer Res; 1989; 9(3):715-21. PubMed ID: 2548435
[TBL] [Abstract][Full Text] [Related]
22. Expression of intracisternal A-particle retrotransposons in primary tumors of oncogene-expressing transgenic mice.
Dupressoir A; Heidmann T
Oncogene; 1997 Jun; 14(24):2951-8. PubMed ID: 9205102
[TBL] [Abstract][Full Text] [Related]
23. Tumorigenic conversion of primary human esophageal epithelial cells using oncogene combinations in the absence of exogenous Ras.
Kim SH; Nakagawa H; Navaraj A; Naomoto Y; Klein-Szanto AJ; Rustgi AK; El-Deiry WS
Cancer Res; 2006 Nov; 66(21):10415-24. PubMed ID: 17079462
[TBL] [Abstract][Full Text] [Related]
24. "Sub-threshold neoplastic states" created in transgenic mice.
Rassoulzadegan M; Cuzin F
Oncogene Res; 1987 Jun; 1(1):1-6. PubMed ID: 2835726
[TBL] [Abstract][Full Text] [Related]
25. Cell lines with heterogeneous phenotypes result from a single isolation of albumin-sv40 T-antigen transgenic rat hepatocytes.
Bulera SJ; Haas MJ; Sattler CA; Li Y; Pitot HC
Hepatology; 1997 May; 25(5):1192-203. PubMed ID: 9141438
[TBL] [Abstract][Full Text] [Related]
26. The CD2-scl transgene alters the phenotype and frequency of T-lymphomas in N-ras transgenic or p53 deficient mice.
Curtis DJ; Robb L; Strasser A; Begley CG
Oncogene; 1997 Dec; 15(24):2975-83. PubMed ID: 9416841
[TBL] [Abstract][Full Text] [Related]
27. Genomic imprinting and Igf2 influence liver tumorigenesis and loss of heterozygosity in SV40 T antigen transgenic mice.
Haddad R; Held WA
Cancer Res; 1997 Oct; 57(20):4615-23. PubMed ID: 9377577
[TBL] [Abstract][Full Text] [Related]
28. Oncogene-mediated multistep transformation of C3H10T1/2 cells.
Taparowsky EJ; Heaney ML; Parsons JT
Cancer Res; 1987 Aug; 47(15):4125-9. PubMed ID: 3300959
[TBL] [Abstract][Full Text] [Related]
29. Increased alpha2,6 sialylation of N-glycans in a transgenic mouse model of hepatocellular carcinoma.
Pousset D; Piller V; Bureaud N; Monsigny M; Piller F
Cancer Res; 1997 Oct; 57(19):4249-56. PubMed ID: 9331085
[TBL] [Abstract][Full Text] [Related]
30. Alterations in the methylation status of ras oncogenes in B6C3F1 mouse liver tumors.
Vorce RL; Goodman JI
Prog Clin Biol Res; 1990; 331():335-43. PubMed ID: 2179961
[No Abstract] [Full Text] [Related]
31. Cooperation of Ha-ras and Bcl-2 during multistep skin carcinogenesis.
Lee S; Chari NS; Kim HW; Wang X; Roop DR; Cho SH; DiGiovanni J; McDonnell TJ
Mol Carcinog; 2007 Dec; 46(12):949-57. PubMed ID: 17538944
[TBL] [Abstract][Full Text] [Related]
32. Oncogenic potential of cyclin E in T-cell lymphomagenesis in transgenic mice: evidence for cooperation between cyclin E and Ras but not Myc.
Karsunky H; Geisen C; Schmidt T; Haas K; Zevnik B; Gau E; Möröy T
Oncogene; 1999 Dec; 18(54):7816-24. PubMed ID: 10618723
[TBL] [Abstract][Full Text] [Related]
33. [The mouse ovarian surface epithelium cells (MOSE) transformation induced by c-myc/K-ras in].
Yao DS; Li L; Garson K; Vanderhyden BC
Zhonghua Zhong Liu Za Zhi; 2006 Dec; 28(12):881-5. PubMed ID: 17533735
[TBL] [Abstract][Full Text] [Related]
34. Elevation of 1,2-diacylglycerol in ras-transformed neonatal liver and pancreas of transgenic mice.
Wilkison WO; Sandgren EP; Palmiter RD; Brinster RL; Bell RM
Oncogene; 1989 May; 4(5):625-8. PubMed ID: 2657577
[TBL] [Abstract][Full Text] [Related]
35. NTP Toxicology and Carcinogenesis Studies of Oxazepam (CAS No. 604-75-1) in Swiss-Webster and B6C3F1 Mice (Feed Studies).
National Toxicology Program
Natl Toxicol Program Tech Rep Ser; 1993 Aug; 443():1-321. PubMed ID: 12595920
[TBL] [Abstract][Full Text] [Related]
36. The promoter of the human cystic fibrosis transmembrane conductance regulator gene directing SV40 T antigen expression induces malignant proliferation of ependymal cells in transgenic mice.
Perraud F; Yoshimura K; Louis B; Dalemans W; Ali-Hadji D; Schultz H; Claudepierre MC; Chartier C; Danel C; Bellocq JP
Oncogene; 1992 May; 7(5):993-7. PubMed ID: 1373882
[TBL] [Abstract][Full Text] [Related]
37. Expression of retroviral sequences and oncogenes in rat liver tumors induced by diethylnitrosamine.
Hsieh LL; Hsiao WL; Peraino C; Maronpot RR; Weinstein IB
Cancer Res; 1987 Jul; 47(13):3421-4. PubMed ID: 3555772
[TBL] [Abstract][Full Text] [Related]
38. A human immunoglobulin gene reduces the incidence of lymphomas in c-Myc-bearing transgenic mice.
Nussenzweig MC; Schmidt EV; Shaw AC; Sinn E; Campos-Torres J; Mathey-Prevot B; Pattengale PK; Leder P
Nature; 1988 Dec; 336(6198):446-50. PubMed ID: 3143076
[TBL] [Abstract][Full Text] [Related]
39. Interaction between Raf and Myc oncogenes in transformation in vivo and in vitro.
Cleveland JL; Jansen HW; Bister K; Fredrickson TN; Morse HC; Ihle JN; Rapp UR
J Cell Biochem; 1986; 30(3):195-218. PubMed ID: 3084503
[TBL] [Abstract][Full Text] [Related]
40. Embryonal tumors from transgenic mouse zygotes carrying human activated c-Ha-ras genes.
Katsuki M; Kimura M; Hata J; Takahashi R; Nozawa S; Yokoyama M; Izawa M; Sekiya T; Nishimura S; Nomura T
Mol Biol Med; 1989 Dec; 6(6):567-72. PubMed ID: 2483936
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
